摘要
目的：提高膀胱非移行细胞肿瘤的诊治水平。方法：结合文献对收治的18例膀胱非移行细胞肿瘤的诊断与治疗进行讨论。结果：18例膀胱非移行细胞肿瘤占同期352例膀胱肿瘤的5．1％。其中良性非移行细胞肿瘤3例（16．7％），恶性非移行细胞肿瘤15例（83．3％），后者以鳞癌、腺癌及其与移行细胞癌混合癌为主，占73．3％，且临床分期T3期以上者亦占73．3％。以血尿和膀胱刺激症状为主要临床表现。治疗以膀胱全切除及部分切除为主，其1、3及5年生存率分别为85．7％、66·7％及57．1％。结论：膀胱非移行细胞肿瘤的预后与其临床分期、治疗方式选择有关。
Purpose:To improve the diagnosis and treatment of the bladder nontransitional celltumor. Methods: The methods of diagnosis and treatment were discussed in 18 cases of the bladdernontransitional cell tumor from Jan. l99O to Dec. 1997. Results: l8 cases of the bladder nontransi-tional cell tumor accounted for 5. 1% of 352 bladder tumor patients in the same period, of which16.7% (3 cases) were benign and 83. 3% (15 cases) malignant. Of the later 73. 3 % was squamouscell carcinoma, adenocarcinoma and mixed tumor with transitional cell carcinoma. 73. 3% of thetumors were over T3 stages . Most of the patients had haematuria and irritable bladder symptoms,the proper treatment were partial and total cystectomy. The overall survival rate at 1,3 and 5years was 85. 7%, 66. 7% and 57. 1% respective1y. Concluslous:The prognosis of bladder nontran-sitional cell tumor was apparently related to tumor stage and therapy method.
出处
《临床泌尿外科杂志》
1999年第2期55-57,共3页
Journal of Clinical Urology
